So far, the liver CEACAM1 knockout mice provide an in vivo proof of the key role of impaired hepatic insulin clearance and hyperinsulinemia in the pathogenesis of secondary hepatic insulin resistance. Here, CEACAM1 is linked to hyperinsulinism.